Disclaimer: This article is for educational purposes only and does not replace individualized medical advice. Always follow your healthcare provider’s recommendations.
Your Tandem Mobi buzzes. You open your phone and realize your 68 mg/dL.
Your brain immediately goes into panic mode. Suddenly you’re standing in front of the open fridge chugging juice straight from the carton and a few handfuls of crackers from the pantry “just in case.”
Twenty minutes later?
You’re staring at 220 mg/dL wondering how a low turned into a high so quickly.
When you’re using Control-IQ technology, low blood sugars behave differently than they did before. And the way you treat them should change too.
What is Rebound Hyperglycemia?
Rebound hyperglycemia is the high blood sugar that often follows a low—most commonly because the low was overtreated.
With traditional insulin therapy methods, overtreatment made sense. Insulin kept working in the background no matter what, so you needed enough carbs to “fight” it.
But with automated insulin delivery, systems like Tandem Mobi are already working behind the scenes. As your glucose starts to drop, Control-IQ reduces or even stops basal insulin to help prevent the low from getting worse.
That means by the time you feel low and reach for carbs, there’s often less active insulin working against you than you think—so treating the low the same way you always have can easily lead to a spike afterward.
How Tandem Mobi’s Control IQ+ Protects Against Hypoglycemia
Tandem Mobi isn’t just sitting there looking cute (though, yes, it is tiny and adorable). It’s quietly doing some serious behind-the-scenes work to stop lows before they happen—or at least make them less dramatic when they do.
It does this in two key main ways: it reduces insulin early, and if needed, suspends it completely.
1. It Starts Reducing Insulin Before You’re Actually Low
Control-IQ+ doesn’t wait until you’re already low to do something. It looks at where your CGM is heading and asks: Where will this be in 30 minutes?
If it predicts your glucose will drop to around 112.5 mg/dL or lower, it starts reducing your basal insulin.
This matters because most lows don’t come out of nowhere. They come from insulin that was already delivered and is still working. By reducing insulin early, Control-IQ+ helps prevent the “slow slide into a low” that happens when basal insulin keeps coming in even though your glucose is already trending down.
2. It Can Fully Suspend Insulin If a Low Is Likely
If Control-IQ+ predicts your glucose will drop below 70 mg/dL within the next 30 minutes, it takes a stronger step: it can completely stop basal insulin delivery.
This sets your basal rate to 0 units per hour temporarily.
This is the system actively trying to prevent a low—or at least reduce how severe it becomes.
Instead of insulin continuing to push your glucose down while you’re scrambling for juice, the pump removes the source of the problem.
Treating Low Blood Sugar with Tandem Mobi
Even with Control-IQ doing most of the heavy lifting to prevent drops, sometimes a low still sneaks through. Since the pump has already slowed or suspended insulin, you don’t always need to follow the standard “Rule of 15.”
The 5–10 Gram Strategy
For most mild to moderate lows (55-70 mg/dL), starting with just 5-10 grams of fast-acting carbs is usually enough. Because Control-IQ has already reduced or suspended insulin, your body only needs a gentle nudge to get back into range.
The old-school rule of 15 can lead to over-treating and the dreaded post-low sugar spike that nobody enjoys.
Practical Tips for Tandem Mobi Users Managing Hypoglycemia
Review Your Settings with Your Provider
Frequent lows mean your insulin settings need adjustment. This can include:
- Basal rates: If Control-IQ+ is frequently reducing or suspending insulin, your programmed basal rates may be too high for certain times of day (overnight, pre-exercise, or post-meal).
- Correction factor: An aggressive correction factor can push your glucose too low after a manual or automatic correction bolus.
- Insulin-to-carb ratios: If your ratio delivers too much insulin for small or fast-acting meals/snacks, post-meal glucose can drop sharply.
Review Your Insulin Delivery History
Before correcting a low blood sugar, take a quick peek at what Control-IQ+ has been doing. Check the Mobi app for:
- Basal reductions or suspensions: If Control-IQ+ has already decreased or suspended insulin in the last 30-60 minutes, you may only need a small nudge of carbs to recover.
- Insulin-on-board (IOB): Low IOB combined with a recent basal reduction usually means your glucose can bounce back on its own or with minimal treatment. High IOB means that insulin is still in play so a slightly larger carb dose may be necessary.
Carry Measured Treatments
Treating a low doesn’t have to be a guessing game. Pre-measured options like Transcend Minis make it easy to give just enough carbs without overshooting– especially when Control-IQ+ has already slowed or paused insulin.
The Bottom Line
By time you see a low alert, Control-IQ has likely already reduced or suspended insulin to help prevent further drops. That means treatment often doesn’t need to be as aggressive as what you’ve been accustomed to. A smaller amount of fast-acting carbohydrates, often just 5-10 grams, is enough to recover safely without triggering a rebound high.
References:
Tandem Diabetes Care. Tandem Mobi® System with Control‑IQ Technology Technical User Guide. 2024. Available at: Technical User Guide
PANTHER Program. Device Comparison Chart for Automated Insulin Delivery Systems. Updated December 2025. Available at: Device Comparison Chart
About Amanda Ciprich, MS, RD
Amanda Ciprich, a registered dietitian with a specialization in type 1 diabetes, was diagnosed with T1D herself at the age of 18. With her expertise and personal experience, she has authored two books, including "The Caregiver's Guide to Diabetes: Practical Advice for Caring for Your Loved One." As the founder of T1D Nutritionist, a virtual insurance-based private practice, Amanda provides counseling and guidance to individuals with T1D and their families, supporting them in effectively managing diabetes.
This article was medically reviewed by Amanda Ciprich, MS, RD.
